Spanish Red Biotech Pipeline

Amgen

Olpasiran

Type: Biodrugs/ Drugs
Therapeutic area: Cardiovascular and circulatory systems
Indication: Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD) and elevated lipoprotein
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain